Agenus Inc share price logo

Agenus Inc Share Price

NASDAQ: AGEN

Small Cap

$4.41

-0.38

(-8.04%)

as on

Agenus Inc Stock Performance

as on April 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.36
    $4.70
    downward going graph

    1.13%

    Downside

    6.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.96
    $7.34
    downward going graph

    55.56%

    Downside

    66.44%

    Upside

    downward going graph

Agenus Inc share price movements today

Previous Close
$4.79
Open
$4.64
Volume
1.9M
Day's Low - High
$4.36 - $4.70
52 Week Low - High
$1.96 - $7.34

Agenus Inc Historical Returns

1 Month Return
+ 19.14 %
3 Month Return
+ 30 %
1 Year Return
+ 91.34 %
3 Year Return
-87.58 %
5 Year Return
-92.43 %

Agenus Inc Stock Fundamentals & Key Indicators

Check Agenus Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$169.7M

EPS (TTM)

0.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

1.44

EBITDA

-10.6M

Revenue (TTM)

114.2M

Profit Margin

0.10%

Return On Equity TTM

-1278.83%

Agenus Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Agenus Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$169.7M-92.43%NA0.10%
BUY$41.3B126.09%133.478.45%
BUY$111.7B99.85%28.6532.94%
NA$36.5BNA128.255.37%
BUY$79.2B47.96%18.0531.41%

Stock Returns calculator for Agenus Inc Stock including INR - Dollar returns

The Agenus Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Agenus Inc investment value today

Current value as on today

₹2,08,675

Returns

₹1,08,675

(+108.68%)

Returns from Agenus Inc Stock

₹90,909 (+90.91%)

Dollar Impact

₹17,766 (+17.77%)

Analyst Recommendation on Agenus Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Agenus Inc. Average target price of $15.5

Agenus Inc Share Price Target

Get share price movements and forecasts by analysts on Agenus Inc.

What analysts predicted

71.55%UPSIDE

Target Price

$15.5

Current Price

$4.41

Analyzed by

11 Analysts

Target

$15.50

Agenus Inc target price $15.5, a slight upside of 71.55% compared to current price of $4.41. According to 11 analysts rating.

Agenus Inc Stock’s Investor Sentiment and Interest

Search interest for Agenus Inc Stock has increased by 70% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:70% versus previous 30 day period

Agenus Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
24
83
28
23
25
26
24
25
30
34
Gross Profit
-27
16
24
-13
-16
-7
2
-1
5
33
Operating Income
-46
-4
-32
-30
-31
-25
-13
-16
-4
14
EBITDA
-43
0
-30
-19
-28
-22
-10
-13
80
14
Interest Expense
18
44
29
31
35
20
12
13
13
16
Depreciation
2
5
3
3
3
3
3
3
3
0
Income Before Tax
-64
-48
-63
-54
-67
-46
-26
-30
63
-10
Income Tax Expense
16
-2
-1
-1
-
-
-
-
-
-
Net Income
-62
-46
-61
-53
-66
-45
-25
-27
63
-10
Net Profit Margin
-255.82%
-55.24%
-220.98%
-225.79%
-264.36%
-170.88%
-104.99%
-108.81%
211.39%
-30.93%

Agenus Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
22
42
36
150
88
295
98
156
103
114
Gross Profit
-72
-73
-87
-18
-56
113
-99
-81
-52
103
Operating Income
-107
-103
-123
-70
-117
25
-179
-159
-120
-20
EBITDA
-104
-95
-130
-63
-114
43
-161
-145
-101
-10
Interest Expense
17
18
25
41
61
65
61
97
117
55
Depreciation
-
6
6
6
7
6
6
10
13
9
Income Before Tax
-126
-120
-162
-111
-182
-28
-230
-257
-232
-3
Income Tax Expense
-2
-9
-12
37
57
65
40
-11
-
-
Net Income
-126
-120
-159
-107
-180
-23
-220
-245
-227
0
Net Profit Margin
-562.60%
-281.48%
-434.14%
-71.75%
-205.19%
-8.09%
-224.51%
-157.22%
-219.61%
0.10%

Agenus Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-48
-63
-54
-67
-45
-26
-30
63
-239
Operating Cash Flow
-40
-38
-38
-53
-28
-25
-20
-14
-16
Investing Cash Flow
2
0
0
0
0
0
0
0
0
Financing Cash Flow
7
14
79
4
24
3
10
6
15
Change in Cash
-30
-23
40
-48
-4
-21
-8
-7
0

Agenus Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-120
-162
-111
-182
-28
-230
-257
-232
-232
Operating Cash Flow
-94
-131
-18
-139
10
-175
-224
-158
-158
Investing Cash Flow
2
-3
-4
-4
-43
-33
3
0
0
Financing Cash Flow
80
128
31
183
225
95
119
122
122
Change in Cash
-11
-7
8
40
192
-113
-101
-35
-35

Global Institutional Holdings in Agenus Inc

Funds
Holdings
Geode Capital Management, LLC
0.97%
Millennium Management LLC
0.96%
Panagora Asset Management Inc
0.42%
Susquehanna International Group, LLP
0.53%
Goldman Sachs Group Inc
0.49%

Insights on Agenus Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AGEN stock has moved up by 29.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 24.06M → 34.20M (in $), with an average increase of 11.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 111.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 63.91M → -10.57M (in $), with an average decrease of 116.6% per quarter

About Agenus Inc

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
OrganisationAgenus Inc
Headquarters3 Forbes Road, Lexington, MA, United States, 02421-7305
IndustryBiotechnology
CEODr. Garo H. Armen Ph.D.
E-voting on sharesClick here to vote

Key Management of Agenus Inc

Name

Title

Mr. Austin Charette

Senior Director, Financial Reporting and Compliance & Principal Accounting Officer

Mr. Zack Armen

Vice President of Investor Relations & Corporate Development

Ms. Tracy Mazza Clemente

Chief People Officer

Dr. Todd Jude Yancey M.D.

Member of Advisory Board & Chief Strategic Advisor

Dr. Garo H. Armen Ph.D.

Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman

Dr. Steven J. O'Day M.D., Ph.D.

Chief Medical Officer

Ms. Stefanie Perna-Nacar

Chief Communications & Government Relations Officer

Dr. Robin G. Taylor M.B.A., Ph.D.

Chief Commercial Officer

Dr. Jennifer S. Buell Ph.D.

Director and President & CEO of MiNK Therapeutics

Craig Winter

Chief Information Officer

FAQs

What is Agenus Inc share price today?

Agenus Inc share price today is $4.41 as on at the close of the market. Agenus Inc share today touched a day high of $4.7 and a low of $4.36.

What is the 52 week high and 52 week low for Agenus Inc share?

Agenus Inc share touched a 52 week high of $7.34 on and a 52 week low of $1.96 on . Agenus Inc stock price today i.e. is closed at $4.41,which is 39.92% down from its 52 week high and 125.00% up from its 52 week low.

What is Agenus Inc's market capitalisation today?

Agenus Inc market capitalisation is $0.00T as on .

How to invest in Agenus Inc Stock (AGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Agenus Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agenus Inc Shares that will get you 0.3401 shares as per Agenus Inc share price of $4.41 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Agenus Inc Stock (AGEN) from India?

Indian investors can start investing in Agenus Inc (AGEN) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Agenus Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Agenus Inc share’s latest price of $4.41 as on April 21, 2026 at 1:29 am IST, you will get 2.2676 shares of Agenus Inc. Learn more about fractional shares .

What are the returns that Agenus Inc has given to Indian investors in the last 5 years?

Agenus Inc stock has given -92.43% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?